Centre for Cancer Research

Cancer biology publications

2010
Crosbie JC, Anderson RL, Rothkamm K, Restall CM, Cann L, Ruwanpura S, Meachem S, Yagi N, Svalbe I, Lewis RA, Williams BRG, Rogers PAW (2010) Tumor cell response to synchrotron microbeam radiation therapy differs markedly from cells in normal tissues. Int J Rad Oncol Biol Phys 77:886-894.

Thomsen MK, Ambroisine L, Wynn S, Cheah KSE, Foster CS, Fisher G, Berney DM, Møller H, Reuter VE, Scardino P, Cuzick J, Ragavan N, Singh PB, Martin FL, Butler CM, Cooper CS, Swain A (2010) SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res 70:979-987.

Yuan X-L, Chen L, Li M-X, Dong P, Xue J, Wang J, Zhang T-T, Wang X-A, Zhang F-M, Ge H-L, Shen L-S, Xu D (2010) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134:277-288.

2009
Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat M-L, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, kConFab, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15:907-913.

Shen L-S, Wang J, Shen D-F, Yuan X-L, Dong P, Li M-X, Xue J, Zhang F-M, Ge H-L, Xu D (2009) CD4⁺CD25⁺CD127^low/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin Immunol 131:109-118.

2007
Sengupta S, Kim KS, Berk MP, Oates R, Escobar P, Belinson J, Li W, Lindner DJ, Williams B, Xu Y (2007) Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene 26:2894-2901.

Singh AD, Sisley K, Xu Y, Li J, Faber P, Plummer SJ, Mudhar HS, Rennie IG, Kessler PM, Casey G, Williams BRG (2007) Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol 91:1385-1392.